New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 3, 2014
08:55 EDTBIIBBiogen's TECFIDERA approved in the European Union
Biogen announced that TECFIDERA has been approved by the European Commission as a first-line oral treatment for people with relapsing-remitting multiple sclerosis. Biogen will begin to introduce TECFIDERA in initial European Union countries in the coming weeks. The EC approval is based on a clinical development program that included two global Phase 3 clinical trials, DEFINE and CONFIRM, as well as an ongoing extension study, ENDORSE, in which some patients have been followed for up to six and a half years. TECFIDERA has been clinically shown to "significantly" reduce important measures of disease activity, including relapses and the development of brain lesions, as well as to slow disability progression, while demonstrating a favorable safety and tolerability profile.
News For BIIB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 4, 2015
08:20 EDTBIIBBass slams PTO for blocking patent challenge, Business Insider reports
Subscribe for More Information
September 2, 2015
11:39 EDTBIIBBass denied request for review of Biogen multiple sclerosis drug patent
Subscribe for More Information
11:26 EDTBIIBPatent office denies Bass request to review Tecfidera patent, Reuters reports
Subscribe for More Information
September 1, 2015
10:05 EDTBIIBOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: 8point3 Energy (CAFD) initiated with an Equal Weight at Barclays... AMAG Pharmaceuticals (AMAG) initiated with an Outperform at Raymond James... Acadia (ACHC) initiated with an Outperform at Leerink... Acorda Therapeutics (ACOR) initiated with a Market Perform at Raymond James... Alexion (ALXN) initiated with a Strong Buy at Raymond James... Amedisys (AMED) initiated with an Outperform at Wells Fargo... Amgen (AMGN) initiated with a Market Perform at Raymond James... Amplify Snack Brands (BETR) initiated with a Neutral at Credit Suisse... BioMarin (BMRN) initiated with an Outperform at Raymond James... Biogen (BIIB) initiated with a Strong Buy at Raymond James... Celgene (CELG) initiated with a Strong Buy at Raymond James... CoreLogic (CLGX) initiated with a Neutral at SunTrust... Digi International (DGII) initiated with an Overweight at Stephens... First Solar (FSLR) initiated with an Overweight at Barclays... LHC Group (LHCG) initiated with an Outperform at Wells Fargo... Lancaster Colony (LANC) initiated with a Buy at BB&T... McCormick (MKC) initiated with a Buy at BB&T... NephroGenex (NRX) initiated with a Buy at H.C. Wainwright... Omega Protein (OME) initiated with a Hold at BB&T... Preferred Apartment (APTS) initiated with an Outperform at FBR Capital... Qorvo (QRVO) initiated with an Outperform at CLSA... Regeneron (REGN) initiated with an Outperform at Raymond James... Skyworks (SWKS) initiated with an Outperform at CLSA... SunPower (SPWR) initiated with an Equal Weight at Barclays... TESARO (TSRO) initiated with a Strong Buy at Raymond James... Ultragenyx (RARE) initiated with an Outperform at Raymond James... VEREIT (VER) initiated with a Buy at Goldman... Westmoreland (WLB) initiated with an Outperform at BMO Capital.
August 31, 2015
19:26 EDTBIIBBiogen initiated with a Strong Buy at Raymond James
Target $400.
05:59 EDTBIIBStocks with implied volatility below IV index mean; BIIB TEVA
Stocks with implied volatility below IV index mean; Biogen (BIIB) 37, Teva (TEVA) 31 according to iVolatility.
August 28, 2015
09:15 EDTBIIBBiogen participates in a conference call with Barclays
Subscribe for More Information
06:01 EDTBIIBStocks with implied volatility below IV index mean; BIIB TEVA
Stocks with implied volatility below IV index mean; Biogen (BIIB) 38, Teva (TEVA) 31 according to iVolatility.
August 27, 2015
07:16 EDTBIIBApplied Genetic announces achievement of XLRS patient enrollement milestone
Subscribe for More Information
August 25, 2015
16:43 EDTBIIBOn The Fly: Top stock stories for Tuesday
Subscribe for More Information
09:03 EDTBIIBAcorda has major overhang removed by IPR denials, says Leerink
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use